Headquartered in Durham, NC·Fiscal year ends December·NYSE: IQV·iqvia.com
About IQVIA
IQVIA Holdings Inc. (NYSE: IQV) is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company operates through two segments: Commercial Solutions, which provides analytics, consulting, patient solutions, commercial engagement services, and AI-powered solutions to help biopharmaceutical companies commercialize products; and Research & Development Solutions, which offers clinical trial management, contract research, and related services to support drug development. IQVIA's offerings are powered by its Connected Intelligence platform, which combines large-scale health data assets, Healthcare-grade AI, advanced analytics, and domain expertise. The company employs approximately 94,000 people across more than 100 countries, serving biotech, medical device, pharmaceutical companies, medical researchers, government agencies, and payers. IQVIA maintains a significant contracted R&D backlog and emphasizes responsible AI deployment with privacy-enhancing technologies and regulatory compliance safeguards. Updated
While most software companies were retreating, Paycom made an aggressive and unconventional bet on itself, and the market delivered a verdict that caught even seasoned analysts off guard.
Pre-Market Stock Futures: Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX | SPCX Price Prediction) or SpaceX IPO rush is starting to fade…
Thursday's top analyst upgrades and downgrades included American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines, Taiwan Semiconductor Manufacturing and Toast.
Monay's top analyst upgrades and downgrades included Block, Boeing, Chegg, Chesapeake Energy, DexCom, Duke Realty, JPMorgan Chase, Kraft Heinz, Merck, Netflix, Patterson-UTI Energy and TechnipFMC.
Monday's top analyst upgrades, downgrades and initiations included ABB, Apple, Baidu, Casper Sleep, General Electric, Groupon, JPMorgan, Micron Technology, PPD, Verizon Communications and Wayfair.
IQVIA Holdings Inc. (NYSE: IQV) is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries.
What is the IQV stock price target?
24/7 Wall St.'s 12-month price target for IQV is $311.97, rated Buy. The Wall Street consensus target is $295.05. IQV price prediction →